Molecular factors involved in the hypolipidemic- and insulin-sensitizing effects of a ginger (Zingiber officinale Roscoe) extract in rats fed a high-fat diet

Applied Physiology, Nutrition and Metabolism

Volumn 42, Issue 2, 2017, Pages 209-215

  De Las Heras, Natalia ^a   Valero Muñoz, María ^a   Martín Fernández, Beatriz ^a   Ballesteros, Sandra ^a   López Farré, Antonio ^a   Ruiz Roso, Baltasar ^a   Lahera, Vicente ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Dyslipidemia; Ginger; Hepatic steatosis; Insulin resistance; Overweight

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, RAT; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CATECHOL DERIVATIVE; FATTY ALCOHOL; GINGEROL; GLUCOSE TRANSPORTER 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT EXTRACT; PPAR GAMMA, RAT; SLC2A2 PROTEIN, RAT;

ADVERSE EFFECTS; ANIMAL; BLOOD; CHEMISTRY; DIABETES MELLITUS, TYPE 2; DIET THERAPY; GINGER; HYPERLIPIDEMIAS; INSULIN RESISTANCE; LIPID DIET; LIVER; MALE; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PLANT ROOT; UPREGULATION; WISTAR RAT;

ADIPONECTIN; ANIMALS; CATECHOLS; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; FATTY ALCOHOLS; GINGER; GLUCOSE TRANSPORTER TYPE 2; HYPERLIPIDEMIAS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; INSULIN RESISTANCE; LIVER; MALE; OVERWEIGHT; PLANT EXTRACTS; PLANT ROOTS; PPAR ALPHA; PPAR GAMMA; RATS, WISTAR; UP-REGULATION;

EID: 85011320819     PISSN: 17155312     EISSN: 17155320     Source Type: Journal    
DOI: 10.1139/apnm-2016-0374     Document Type: Article

References (48)

1. Ali, B.H., Blunden, G., Tanira, M.O., and Nemmar, A. 2008. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem. Toxicol. 46: 409-420. doi:10.1016/j.fct.2007.09.085.PMID:17950516.
2. Asyifah, M.R., Lu, K., Ting, H.L., and Zhang, D. 2014. Hidden potential of tropical fruit waste components as a useful source of remedy for obesity. J. Agric. Food Chem. 62: 3505-3516. doi:10.1021/jf5007352.PMID:24670153.
3. Bhandari, U., Kanojia, R., and Pillai, K.K. 2005. Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. J. Ethnopharmacol. 97: 227-230. doi:10.1016/j.jep.2004.11.011.PMID:15707757.
4. Blanco-Rivero, J., de las Heras, N., Martín-Fernández, B., Cachofeiro, V., Lahera, V., and Balfagón, G. 2011. Rosuvastatin restored adrenergic and nitrergic function in mesenteric arteries from obese rats. Br. J. Pharmacol. 162: 271-285. doi:10.1111/j.1476-5381.2010.01030.x.PMID:20840472.
5. Brahmbhatt, M., Gundala, S.R., Asif, G., Shamsi, S.A., and Aneja, R. 2013. Ginger phytochemicals exhibit synergy to inhibit prostate cancer cell proliferation. Nutr. Cancer, 65: 263-272. doi:10.1080/01635581.2013.749925.PMID:23441614.
6. Braunersreuther, V., Viviani, G.L., Mach, F., and Montecucco, F. 2012. Role of cytokines and chemokines in non-alcoholic fatty liver disease. World J. Gastroenterol. 18: 727-735. doi:10.3748/wjg.v18.i8.727.PMID:22371632.
7. Caiozzi, G., Wong, B.S., and Ricketts, M.L. 2012. Dietary modification of metabolic pathways via nuclear hormone receptors. Cell Biochem. Funct. 30: 531-551. doi:10.1002/cbf.2842.PMID:23027406.
8. Dabaghzadeh, F., Khalili, H., and Dashti-Khavidaki, S. 2014. Ginger for prevention or treatment of drug-induced nausea and vomiting. Curr. Clin. Pharmacol. 9: 387-394. doi:10.2174/1574884708666131111205736.PMID:24218997.
9. de las Heras, N., Martín-Fernández, B., Miana, M., Ballesteros, S., Oubiña, M.P., López-Farré, A.J., et al. 2009. The protective effect of irbesartan in rats fed a high fat diet is associated with modification of leptin-adiponectin imbalance. J. Hypertens. 27(Suppl.): S37-S41. doi:10.1097/01.hjh.0000358836.64052.43.PMID:19633450.
10. de las Heras, N., Valero-Muñoz, M., Ballesteros, S., Gómez-Hernández, A., Martín-Fernández, B., Blanco-Rivero, J., et al. 2013. Factors involved in rosuvastatin induction of insulin sensitization in rats fed a high fat diet. Nutr. Metab. Cardiovasc. Dis. 23: 1107-1114. doi:10.1016/j.numecd.2012.11.009.PMID:23434394.
11. Dongare, S., Gupta, S.K., Mathur, R., Saxena, R., Mathur, S., Agarwal, R., et al. 2016. Zingiber officinale attenuates retinal microvascular changes in diabetic rats via anti-inflammatory and antiangiogenic mechanisms. Mol. Vis. 22: 599-609. PMID:27293376.
12. ElRokh, E.S.M., Yassin, N.A., El-Shenawy, S.M., and Ibrahim, B.M. 2010. Antihypercholesterolaemic effect of ginger rhizome (Zingiber officinale) in rats. Inflammopharmacology, 18: 309-315. doi:10.1007/s10787-010-0053-5.PMID:20730603.
13. Fabbrini, E., Sullivan, S., and Klein, S. 2010. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology, 51: 679-689. doi:10.1002/hep.23280.PMID:20041406.
14. Franco-Robles, E., Campos-Cervantes, A., Murillo-Ortiz, B.O., Segovia, J., López-Briones, S., Vergara, P., et al. 2014. Effects of curcumin on brain-derived neurotrophic factor levels and oxidative damage in obesity and diabetes. Appl. Physiol. Nutr. Metab. 39(2): 211-218. doi:10.1139/apnm-2013-0133.PMID:24476477.
15. Fuhrman, B., Rosenblat, M., Hayek, T., Coleman, R., and Aviram, M. 2000. Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice. J. Nutr. 130: 1124-1131. PMID:10801908.
16. Giby, V.G., and Ajith, T.A. 2014. Role of adipokines and peroxisome proliferatoractivated receptors in nonalcoholic fatty liver disease. World J. Hepatol. 6: 570-579. doi:10.4254/wjh.v6.i8.570.PMID:25232450.
17. Gimeno, R.E., and Cao, J. 2008. Thematic review series: glycerolipids. Mammalian glycerol-3-phosphate acyltransferases: new genes for an old activity. J. Lipid. Res. 49: 2079-2088. doi:10.1194/jlr.R800013-JLR200.PMID:18658143.
18. Grant, K.L., and Lutz, R.B. 2000. Ginger. Am. J. Health. Syst. Pharm. 57: 945-947. PMID:10832493.
19. Heath, D.D., Pruitt, M.A., Brenner, D.E., and Rock, C.L. 2003. Curcumin in plasma and urine: quantitation by high-performance liquid chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 783: 287-295. doi:10.1016/S1570-0232(02)00714-6.PMID:12450549.
20. Hügel, H.M. 2015. Brain food for Alzheimer-free ageing: focus on herbal medicines. Adv. Exp. Med. Biol. 863: 95-116. doi:10.1007/978-3-319-18365-7_5.PMID:26092628.
21. Jiang, H., Xie, Z., Koo, H.J., McLaughlin, S.P., Timmermann, B.N., and Gang, D.R. 2006. Metabolic profiling and phylogenetic analysis of medicinal Zingiber species: tools for authentication of ginger (Zingiber officinale Rosc.). Phytochemistry, 67: 1673-1685. doi:10.1016/j.phytochem.2005.08.001.PMID:16169024.
22. Jiménez-Flores, L.M., López-Briones, S., Macías-Cervantes, M.H., Ramírez-Emiliano, J., and Pérez-Vázquez, V. 2014. A PPARγ, NF-κB and AMPK-dependent mechanism may be involved in the beneficial effects of curcumin in the diabetic db/db mice liver. Molecules, 19: 8289-8302. doi:10.3390/molecules19068289.PMID:24945581.
23. Kadowaki, T., and Yamauchi, T. 2005. Adiponectin and adiponectin receptors. Endocr. Rev. 26: 439-451. doi:10.1210/er.2005-0005.PMID:15897298.
24. Kahn, S.E., Hull, R.L., and Utzschneider, K.M. 2006. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature, 444: 840-846. doi:10.1038/nature05482.PMID:17167471.
25. Kato, A., Higuchi, Y., Goto, H., Kizu, H., Okamoto, T., Asano, N., et al. 2006. Inhibitory effects of Zingiber officinale Roscoe derived components on aldose reductase activity in vitro and in vivo. J. Agric. Food Chem. 54: 6640-6644. doi:10.1021/jf061599a.PMID:16939321.
26. Kim, H.I., and Ahn, Y.H. 2004. Role of peroxisome proliferator-activated receptorgamma in the glucose-sensing apparatus of liver and beta-cells. Diabetes, 53: S60-S65. doi:10.2337/diabetes.53.2007.S60.PMID:14749267.
27. Leask, A., and Abraham, D.J. 2004. TGF-β signaling and the fibrotic response. FASEB J. 18: 816-827. doi:10.1096/fj.03-1273rev.PMID:15117886.
28. Li, X.H., McGrath, K.C., Nammi, S., Heather, A.K., and Roufogalis, B.D. 2012a. Attenuation of liver pro-inflammatory responses by Zingiber officinale via inhibition of NF-kappa B activation in high-fat diet-fed rats. Basic Clin. Pharmacol. Toxicol. 110: 238-244. doi:10.1111/j.1742-7843.2011.00791.x.PMID:21902812.
29. Li, Y., Tran, V.H., Duke, C.C., and Roufogalis, B.D. 2012b. Gingerols of Zingiber officinale enhance glucose uptake by increasing cell surface GLUT4 in cultured L6 myotubes. Planta Med. 78: 1549-1555. doi:10.1055/s-0032-1315041.PMID:22828920.
30. Maeda, N., Takahashi, M., Funahashi, T., Kihara, S., Nishizawa, H., Kishida, K., et al. 2001. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes, 50: 2094-2099. doi:10.2337/diabetes.50.9.2094.PMID:11522676.
31. Martin, G., Schoonjans, K., Staels, B., and Auwerx, J. 1997. Coordinate regulation of the expression of the fatty acid transport protein and Acyl-CoA synthetase genes by PPARα and PPARγ activators. J. Biol. Chem. 272: 28210-28217. doi:10.1074/jbc.272.45.28210.PMID:9353271.
32. Martín-Fernández, B., de las Heras, N., Valero-Muñoz, M., Ballesteros, S., Yao, Y.Z., Stanton, P.G., et al. 2014. Beneficial effects of proanthocyanidins in the cardiac alterations induced by aldosterone in rat heart through mineralocorticoid receptor blockade. PLoS ONE, 9: e111104. doi:10.1371/journal.pone.0111104.PMID:25353961.
33. Méndez-Sánchez, N., Arrese, M., Zamora-Valdés, D., and Uribe, M. 2007. Current concepts in the pathogenesis of nonalcoholic fatty liver disease. Liver Int. 27: 423-433. doi:10.1111/j.1478-3231.2007.01483.x.PMID:17403181.
34. Meshkani, R., and Adeli, K. 2009. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin. Biochem. 42: 1331-1346. doi:10.1016/j.clinbiochem.2009.05.018.PMID:19501581.
35. Nammi, S., Sreemantula, S., and Roufogalis, B.D. 2009. Protective effects of ethanolic extract of Zingiber officinale rhizome on the development of metabolic syndrome in high-fat diet-fed rats. Basic Clin. Pharmacol. Toxicol. 104: 366-373. doi:10.1111/j.1742-7843.2008.00362.x.PMID:19413656.
36. Okamoto, M., Irii, H., Tahara, Y., Ishii, H., Hirao, A., Udagawa, H., et al. 2011. Synthesis of a new [6]-gingerol analogue and its protective effect with respect to the development of metabolic syndrome in mice fed a high-fat diet. J. Med. Chem. 54: 6295-6304. doi:10.1021/jm200662c.PMID:21851089.
37. Rodgers, J.T., Lerin, C., Haas, W., Gygi, S.P., Spiegelman, B.M., and Puigserver, P. 2005. Nutrient control of glucose homeostasis through a complex of pgc-1alpha and sirt1. Nature, 434: 113-118. doi:10.1038/nature03354.PMID:15744310.
38. Sahebkar, A. 2011. Potential efficacy of ginger as a natural supplement for nonalcoholic fatty liver disease. World J. Gastroenterol. 17: 271-272. doi:10.3748/wjg.v17.i2.271.PMID:21246004.
39. Saravanan, G., Ponmurugan, P., Deepa, M.A., and Senthilkumar, B. 2014. Antiobesity action of gingerol: effect on lipid profile, insulin, leptin, amylase and lipase in male obese rats induced by a high-fat diet. J. Sci. Food Agric. 94: 2972-2977. doi:10.1002/jsfa.6642.PMID:24615565.
40. Schwertner, H.A., and Rios, D.C. 2007. High-performance liquid chromatographic analysis of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol in gingercontaining dietary supplements, spices, teas, and beverages. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 856: 41-47. doi:10.1016/j.jchromb.2007.05.011.PMID:17561453.
41. Spiegelman, B.M., and Flier, J.S. 2001. Obesity and the regulation of energy balance. Cell, 104: 531-543. doi:10.1016/S0092-8674(01)00240-9.PMID:11239410.
42. Sutra, T., Oiry, C., Azay-Milhau, J., Youl, E., Magous, R., Teissèdre, P.L., et al. 2008. Preventive effects of nutritional doses of polyphenolic molecules on cardiac fibrosis associated with metabolic syndrome: involvement of osteopontin and oxidative stress. J. Agric. Food. Chem. 56: 11683-11687. doi:10.1021/jf802357g.PMID:19049292.
43. Trigueros, L., Peña, S., Ugidos, A.V., Sayas-Barberá, E., Pérez-Álvarez, J.A., and Sendra, E. 2013. Food ingredients as anti-obesity agents: a review. Crit. Rev. Food Sci. Nutr. 53: 929-942. doi:10.1080/10408398.2011.574215.PMID:23768185.
44. Tyagi, S., Gupta, P., Saini, A.S., Kaushal, C., and Sharma, S. 2011. The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases. J. Adv. Pharm. Technol. Res. 2: 236-240. doi:10.4103/2231-4040.90879.PMID:22247890.
45. Valero-Muñoz, M., Martin-Fernandez, B., Ballesteros, S., Lahera, V., Martínez-Martínez, E., Blanco-Rivero, J., et al. 2013. Relevance of vascular peroxisome proliferator-activated receptor gamma coactivator-1alpha to molecular alterations in atherosclerosis. Exp. Physiol. 98: 999-1008. doi:10.1113/expphysiol.2012.070557.PMID:23335007.
46. Vázquez-Vela, M.E., Torres, N., and Tovar, A.R. 2008. White adipose tissue as endocrine organ and its role in obesity. Arch. Med. Res. 39: 715-728. doi:10.1016/j.arcmed.2008.09.005.PMID:18996284.
47. Wang, S., Moustaid-Moussa, N., Chen, L., Mo, H., Shastri, A., Su, R., et al. 2014. Novel insights of dietary polyphenols and obesity. Nutr. Biochem. 25: 1-18. doi:10.1016/j.jnutbio.2013.09.001.PMID:24314860.
48. Yoshino, S., Kim, M., Awa, R., Kuwahara, H., Kano, Y., and Kawada, T. 2014. Kaempferia parviflora extract increases energy consumption through activation of BAT in mice. Food Sci. Nutr. 2: 634-637. doi:10.1002/fsn3.144.PMID:25493179.